Identification of Fc Gamma Receptor Glycoforms That Produce Differential Binding Kinetics for Rituximab*

Fc gamma receptors (FcγR) bind the Fc region of antibodies and therefore play a prominent role in antibody-dependent cell-based immune responses such as ADCC, CDC and ADCP. The immune effector cell activity is directly linked to a productive molecular engagement of FcγRs where both the protein and glycan moiety of antibody and receptor can affect the interaction and in the present study we focus on the role of the FcγR glycans in this interaction. We provide a complete description of the glycan composition of Chinese hamster ovary (CHO) expressed human Fcγ receptors RI (CD64), RIIaArg131/His131 (CD32a), RIIb (CD32b) and RIIIaPhe158/Val158 (CD16a) and analyze the role of the glycans in the binding mechanism with IgG. The interactions of the monoclonal antibody rituximab with each FcγR were characterized and we discuss the CHO-FcγRIIIaPhe158/Val158 and CHO-FcγRI interactions and compare them to the equivalent interactions with human (HEK293) and murine (NS0) produced receptors. Our results reveal clear differences in the binding profiles of rituximab, which we attribute in each case to the differences in host cell-dependent FcγR glycosylation. The glycan profiles of CHO expressed FcγRI and FcγRIIIaPhe158/Val158 were compared with the glycan profiles of the receptors expressed in NS0 and HEK293 cells and we show that the glycan type and abundance differs significantly between the receptors and that these glycan differences lead to the observed differences in the respective FcγR binding patterns with rituximab. Oligomannose structures are prevalent on FcγRI from each source and likely contribute to the high affinity rituximab interaction through a stabilization effect. On FcγRI and FcγRIIIa large and sialylated glycans have a negative impact on rituximab binding, likely through destabilization of the interaction. In conclusion, the data show that the IgG1-FcγR binding kinetics differ depending on the glycosylation of the FcγR and further support a stabilizing role of FcγR glycans in the antibody binding interaction.

[1]  John R Yates,et al.  Global site-specific N-glycosylation analysis of HIV envelope glycoprotein , 2017, Nature Communications.

[2]  M. Wormald,et al.  Fc gamma receptors: glycobiology and therapeutic prospects , 2016, Journal of inflammation research.

[3]  G. Subedi,et al.  The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor , 2016, mAbs.

[4]  R. Karlsson,et al.  Comparison of surface plasmon resonance binding curves for characterization of protein interactions and analysis of screening data. , 2016, Analytical biochemistry.

[5]  Y. Rombouts,et al.  Recent Advances in Clinical Glycoproteomics of Immunoglobulins (Igs)* , 2016, Molecular & Cellular Proteomics.

[6]  K. Tsumoto,et al.  Structural basis for binding of human IgG1 to its high-affinity human receptor FcγRI , 2015, Nature Communications.

[7]  Jinghua Lu,et al.  Structure of FcγRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding , 2015, Proceedings of the National Academy of Sciences.

[8]  Weston B Struwe,et al.  Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions. , 2014, Journal of proteome research.

[9]  André M Deelder,et al.  Site-specific N-glycosylation analysis of human immunoglobulin e. , 2014, Journal of proteome research.

[10]  M. Christiansen,et al.  Fc gamma receptor 3B (FCGR3B-c.233C>A-rs5030738) polymorphism modifies the protective effect of malaria specific antibodies in Ghanaian children. , 2014, The Journal of infectious diseases.

[11]  M. Wormald,et al.  N-linked glycan structures of the human Fcγ receptors produced in NS0 cells. , 2013, Journal of proteome research.

[12]  C. Fritsch,et al.  Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab , 2013, BioDrugs.

[13]  P. Rudd,et al.  Synergizing metabolic flux analysis and nucleotide sugar metabolism to understand the control of glycosylation of recombinant protein in CHO cells , 2011, BMC biotechnology.

[14]  Jinghua Lu,et al.  Crystal Structure of Fcγ Receptor I and Its Implication in High Affinity γ-Immunoglobulin Binding* , 2011, The Journal of Biological Chemistry.

[15]  Jinghua Lu,et al.  Crystal structure of Fc gamma receptor I and its implication in high affinity gamma-immunoglobulin binding. , 2011 .

[16]  Armin Ruf,et al.  Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose , 2011, Proceedings of the National Academy of Sciences.

[17]  J. Peter-Katalinic,et al.  Cell type-specific and site directed N-glycosylation pattern of FcγRIIIa. , 2011, Journal of proteome research.

[18]  J. Prestegard,et al.  NMR Analysis Demonstrates Immunoglobulin G N-glycans are Accessible and Dynamic , 2011, Nature chemical biology.

[19]  P. Rudd,et al.  Separation of 2-aminobenzamide labeled glycans using hydrophilic interaction chromatography columns packed with 1.7 microm sorbent. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[20]  D. Blanset,et al.  A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies , 2010, Cancer Immunology and Immunotherapy.

[21]  Louise Royle,et al.  Proposal for a standard system for drawing structural diagrams of N‐ and O‐linked carbohydrates and related compounds , 2009, Proteomics.

[22]  P. Bruhns,et al.  Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. , 2009, Blood.

[23]  S. Iida,et al.  The N-linked oligosaccharide at FcγRIIIa Asn-45: an inhibitory element for high FcγRIIIa binding affinity to IgG glycoforms lacking core fucosylation , 2008, Glycobiology.

[24]  Alessio Ceroni,et al.  GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans. , 2008, Journal of proteome research.

[25]  Maria Allhorn,et al.  Human IgG/FcγR Interactions Are Modulated by Streptococcal IgG Glycan Hydrolysis , 2008, PloS one.

[26]  R. Kimberly,et al.  Association of a transmembrane polymorphism of Fcgamma receptor IIb (FCGR2B) with systemic lupus erythematosus in Taiwanese patients. , 2006, Arthritis and rheumatism.

[27]  M. Butler,et al.  Optimisation of the Cellular Metabolism of Glycosylation for Recombinant Proteins Produced by Mammalian Cell Systems , 2006, Cytotechnology.

[28]  P. Umaña,et al.  The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms. , 2006, The Journal of biological chemistry.

[29]  P. Katsamba,et al.  Analyzing a kinetic titration series using affinity biosensors. , 2006, Analytical biochemistry.

[30]  K. Tokunaga,et al.  FcγRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling , 2005 .

[31]  M. Daëron,et al.  Fc receptor biology. , 2003, Annual review of immunology.

[32]  W. Weng,et al.  Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  C. Sautès-Fridman,et al.  N-glycosylation profile of recombinant human soluble Fcγ receptor III , 2002 .

[34]  C. Sautès-Fridman,et al.  N-glycosylation profile of recombinant human soluble Fcgamma receptor III. , 2002, Glycobiology.

[35]  G. Salles,et al.  Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. , 2002, Blood.

[36]  David I. Stuart,et al.  The Human Low Affinity Fcγ Receptors IIa, IIb, and III Bind IgG with Fast Kinetics and Distinct Thermodynamic Properties* , 2001, The Journal of Biological Chemistry.

[37]  C. Sautès-Fridman,et al.  The Structure of a Human Type III Fcγ Receptor in Complex with Fc* , 2001, The Journal of Biological Chemistry.

[38]  Gregory Stephanopoulos,et al.  Metabolic effects on recombinant interferon-gamma glycosylation in continuous culture of Chinese hamster ovary cells , 2000, IBM J. Res. Dev..

[39]  Robert Huber,et al.  The 3.2-Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex , 2000, Nature.

[40]  J. Martín,et al.  Involvement of Fcgamma receptor IIIA genotypes in susceptibility to rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[41]  Gregory Stephanopoulos,et al.  Metabolic effects on recombinant interferon‐γ glycosylation in continuous culture of Chinese hamster ovary cells , 1999 .

[42]  R. Jefferis,et al.  IgG‐Fc‐mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation , 1998, Immunological reviews.

[43]  R. Kimberly,et al.  Antibodies to C1q in systemic lupus erythematosus: characteristics and relation to Fc gamma RIIA alleles. , 1997, Kidney international.

[44]  R. Kimberly,et al.  Cell type-specific glycoforms of Fc gamma RIIIa (CD16): differential ligand binding. , 1997, Journal of immunology.

[45]  R. Kimberly,et al.  A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. , 1997, The Journal of clinical investigation.

[46]  D. Roos,et al.  FcγRIIIa-158V/F Polymorphism Influences the Binding of IgG by Natural Killer Cell FcγRIIIa, Independently of the FcγRIIIa-48L/R/H Phenotype , 1997 .

[47]  D. Roos,et al.  A triallelic Fc gamma receptor type IIIA polymorphism influences the binding of human IgG by NK cell Fc gamma RIIIa. , 1996, Journal of immunology.

[48]  C. Kallenberg,et al.  Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. , 1995, Arthritis and rheumatism.

[49]  R. Feldman,et al.  Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils , 1995, Infection and immunity.

[50]  P. Capel,et al.  Fcã Receptor Iia (Cd32) Heterogeneity In Patients With Recurrent Bacterial Respiratory Tract Infections , 1994 .

[51]  R. Kimberly,et al.  Fc gamma RIII expressed on cultured monocytes is a N-glycosylated transmembrane protein distinct from Fc gamma RIII expressed on natural killer cells. , 1990, Journal of immunology.

[52]  B. Perussia,et al.  Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions , 1989, The Journal of experimental medicine.

[53]  R. Kimberly,et al.  Carbohydrates on human Fc gamma receptors. Interdependence of the classical IgG and nonclassical lectin-binding sites on human Fc gamma RIII expressed on neutrophils. , 1989, Journal of immunology.

[54]  M. Wormald,et al.  Glycosylation and Fc receptors. , 2014, Current topics in microbiology and immunology.

[55]  J. Ravetch,et al.  Fcgamma receptors as regulators of immune responses. , 2008, Nature reviews. Immunology.

[56]  J. Ravetch,et al.  Fcγ receptors as regulators of immune responses , 2008, Nature Reviews Immunology.

[57]  Pauline M Rudd,et al.  Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions. , 2006, Methods in molecular biology.

[58]  K. Tokunaga,et al.  FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. , 2005, Human molecular genetics.

[59]  Y. Qian,et al.  Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. , 2004, Tissue antigens.

[60]  R. Huber,et al.  The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. , 2000, Nature.

[61]  I. Shimada,et al.  N-glycan structures of a recombinant mouse soluble Fcgamma receptor II. , 1998, Glycoconjugate journal.

[62]  D. Roos,et al.  Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype. , 1997, Blood.

[63]  J. V. D. van de Winkel,et al.  Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. , 1994, The Journal of infectious diseases.